Cdc25B is negatively regulated by p53 through Sp1 and NF-Y transcription factors

被引:36
作者
Dalvai, M. [1 ]
Mondesert, O. [1 ]
Bourdon, J-C [2 ]
Ducommun, B. [1 ,3 ]
Dozier, C. [1 ]
机构
[1] Univ Toulouse, CNRS, LBCMCP, UMR 5088, F-31062 Toulouse, France
[2] Univ Dundee, Dept Surg & Mol Oncol, European Associated Lab, INSERM,U858,Coll Med, Dundee, Scotland
[3] CHU Toulouse, Toulouse, France
关键词
Cdc25B; p53; Sp1; NF-Y; CELL-CYCLE REGULATION; WILD-TYPE P53; BREAST-CANCER; DNA-DAMAGE; EXPRESSION; ACTIVATION; PHOSPHATASE; APOPTOSIS; GENES; TRIGGERS;
D O I
10.1038/onc.2010.588
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cdc25B phosphatases function as key players in G2/M cell cycle progression by activating the CDK1-cyclinB1 complexes. They also have an essential role in recovery from the G2/M checkpoint activated in response to DNA damage. Overexpression of Cdc25B results in bypass of the G2/M checkpoint and illegitimate entry into mitosis, and also causes replicative stress, leading to genomic instability. Thus, fine-tuning of Cdc25B expression level is critical for correct cell cycle progression and G2 checkpoint recovery. However, the transcriptional regulation of Cdc25B remains largely unknown. Earlier studies have shown that the tumor suppressor p53 overexpression transcriptionally represses Cdc25B; however, the molecular mechanism of this repression has not yet been elucidated, although it was suggested to occur through the induction of p21. Here we show that Cdc25B is downregulated by the basal level of p53 in multiple cell types. This downregulation also occurs in p21-/- cell lines, indicating that p21 is not required for p53-mediated regulation of Cdc25B. Deletion and mutation analyses of the Cdc25B promoter revealed that downregulation by p53 is dependent on the presence of functional Sp1/Sp3 and NF-Y binding sites. Furthermore, chromatin immuno-precipitation analyses show that p53 binds to the Cdc25B promoter and mediates transcriptional attenuation through the Sp1 and NF-Y transcription factors. Our results suggest that the inability to downregulate Cdc25B after loss of p53 might contribute to tumorigenesis. Oncogene (2011) 30, 2282-2288; doi:10.1038/onc.2010.588; published online 17 January 2011
引用
收藏
页码:2282 / 2288
页数:7
相关论文
共 39 条
  • [1] Phosphorylation of human CDC25B phosphatase by CDK1-cyclin A triggers its proteasome-dependent degradation
    Baldin, V
    Cans, C
    Knibiehler, M
    Ducommun, B
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (52) : 32731 - 32734
  • [2] Alternative splicing of the human CDC25B tyrosine phosphatase. Possible implications for growth control?
    Baldin, V
    Cans, C
    SupertiFurga, G
    Ducommun, B
    [J]. ONCOGENE, 1997, 14 (20) : 2485 - 2495
  • [3] A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response
    Benatti, Paolo
    Basile, Valentina
    Merico, Daniele
    Fantoni, Luca Isaia
    Tagliafico, Enrico
    Imbriano, Carol
    [J]. NUCLEIC ACIDS RESEARCH, 2008, 36 (05) : 1415 - 1428
  • [4] Bocangel D, 2009, ANTICANCER RES, V29, P3741
  • [5] The when and wheres of CDC25 phosphatases
    Boutros, R
    Dozier, C
    Ducommun, B
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2006, 18 (02) : 185 - 191
  • [6] CDC25 phosphatases in cancer cells: key players? Good targets?
    Boutros, Rose
    Lobjois, Valerie
    Ducommun, Bernard
    [J]. NATURE REVIEWS CANCER, 2007, 7 (07) : 495 - 507
  • [7] Transcriptional control of the proliferation cluster by the tumor suppressor p53
    Brosh, Ran
    Rotter, Varda
    [J]. MOLECULAR BIOSYSTEMS, 2010, 6 (01) : 17 - 29
  • [8] A system for stable expression of short interfering RNAs in mammalian cells
    Brummelkamp, TR
    Bernards, R
    Agami, R
    [J]. SCIENCE, 2002, 296 (5567) : 550 - 553
  • [9] Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expression
    Bugler, Beatrix
    Quaranta, Muriel
    Aressy, Bernadette
    Brezak, Marie-Christine
    Prevost, Gregoire
    Ducommun, Bernard
    [J]. MOLECULAR CANCER THERAPEUTICS, 2006, 5 (06) : 1446 - 1451
  • [10] Unscheduled expression of CDC25B in S-phase leads to replicative stress and DNA damage
    Bugler, Beatrix
    Schmitt, Estelle
    Aressy, Bernadette
    Ducommun, Bernard
    [J]. MOLECULAR CANCER, 2010, 9